Abstract
No public abstract is available from the verified source records.
Open public full textRights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureNicholas G. Zaorsky, Gary A. Ezzell, Dean G. Assimos, Anthony V. D'Amico, Alexander R. Gottschalk, Gary S. Gustafson, Sameer R. Keole, Stanley L. Liauw, Shane Lloyd, Patrick W. McLaughlin, Benjamin Movsas, Bradley R. Prestidge, Al V. Taira, Brian J. Davis
Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Cancer statistics, 2015
2015
Time trends and local variation in primary treatment of localized prostate cancer
10.1200/jco.2009.26.0133 · 2010
Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma
10.1016/j.radonc.2009.09.001 · 2009
Outcomes for intermediate risk prostate cancer: Are there advantages for surgery, external radiation, or brachytherapy?
10.1016/j.urolonc.2008.04.001 · 2009
Radical prostatectomy, external beam radiotherapy or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer
10.1016/s0360-3016(03)00784-3 · 2004
Prostate cancer, version 2.2014
10.6004/jnccn.2014.0072 · 2014
ACR appropriateness Criteria(R) Postradical prostatectomy irradiation in prostate cancer
2014
ACR Appropriateness Criteria(R) Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer
10.1097/coc.0000000000000049 · 2014
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
10.1001/jama.280.11.969 · 1998
Systematic review of hypofractionated radiation therapy for prostate cancer
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
10.1016/j.ctrv.2013.01.008 · 2013
Stereotactic body radiation therapy for prostate cancer: Is the technology ready to be the standard of care?
10.1016/j.ctrv.2012.10.003 · 2013
Three-dimensional conformal therapy versus standard radiation therapy in localized carcinoma of prostate: An update
10.3816/cgc.2002.n.011 · 2002
Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?
10.1016/j.ijrobp.2010.01.006 · 2011
Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer
10.1016/j.ijrobp.2007.06.054 · 2008
Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406
10.1016/j.ijrobp.2011.12.070 · 2012
Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study
10.1016/j.ijrobp.2009.01.062 · 2010
Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer
10.1016/s0167-8140(99)00100-0 · 2000
Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer
10.1200/jco.2013.51.1972 · 2013
Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer
10.1001/jama.2012.460 · 2012
Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer
10.1016/j.ijrobp.2011.11.047 · 2012
Stereotactic body radiotherapy as boost for organ-confined prostate cancer
10.1177/153303461000900605 · 2010
Stereotactic body radiation therapy for low, intermediate, and high-risk prostate cancer: Disease control and quality of life
10.1016/j.ijrobp.2011.06.204 · 2011
Quality of life and toxicity after SBRT for organ-confined prostate cancer, a 7-year study
10.3389/fonc.2014.00301 · 2014
Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: Long-term results from Proton Radiation Oncology Group/American College of Radiology 95-09
10.1200/jco.2009.25.8475 · 2010
70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial
10.1016/j.ijrobp.2010.03.049 · 2011
Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer
10.1016/j.ijrobp.2008.02.073 · 2008
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial
10.1016/s1470-2045(07)70143-2 · 2007
Target volume definition in conformal radiotherapy for prostate cancer: Quality assurance in the MRC RT-01 trial
10.1016/s0167-8140(00)00191-2 · 2000
10.1016/j.ijrobp.2014.10.035
10.1016/j.ijrobp.2014.10.035
Unresolved referenced work
Kept as external metadata until matched
State of the art on dose prescription, reporting and recording in intensity-modulated radiation therapy (ICRU report No. 83)
10.1016/j.canrad.2011.04.003 · 2011
Guidelines for primary radiotherapy of patients with prostate cancer
10.1016/j.radonc.2006.05.012 · 2006
Unresolved referenced work
Kept as external metadata until matched
Influence of intrafraction motion on margins for prostate radiotherapy
10.1016/j.ijrobp.2005.12.033 · 2006
Pelvic normal tissue contouring guidelines for radiation therapy: A Radiation Therapy Oncology Group consensus panel atlas
10.1016/j.ijrobp.2012.01.023 · 2012
Radiographic and anatomic basis for prostate contouring errors and methods to improve prostate contouring accuracy
10.1016/j.ijrobp.2009.02.019 · 2010
Interphysician variability in defining the planning target volume in the irradiation of prostate and seminal vesicles
10.1016/s0167-8140(98)00028-0 · 1998
Target definition in prostate, head, and neck
10.1016/j.semradonc.2005.01.005 · 2005
The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer
10.1016/s0360-3016(99)00288-6 · 1999
Can images obtained with high field strength magnetic resonance imaging reduce contouring variability of the prostate?
10.1016/j.ijrobp.2010.03.019 · 2011
Prostate bed motion during intensity-modulated radiotherapy treatment
10.1016/j.ijrobp.2011.11.041 · doi-reference
Post-prostatectomy image-guided radiation therapy: Evaluation of toxicity and inter-fraction variation using online cone-beam CT
10.1111/j.1754-9485.2011.02305.x · doi-reference
Implementation of an image guided intensity-modulated protocol for post-prostatectomy radiotherapy: Planning data and acute toxicity outcomes
10.1111/1754-9485.12043 · doi-reference
Tradeoffs of integrating real-time tracking into IGRT for prostate cancer treatment
10.1088/0031-9155/54/17/n03 · doi-reference
Observations on real-time prostate gland motion using electromagnetic tracking
10.1016/j.ijrobp.2007.11.054 · doi-reference
Accuracy of a wireless localization system for radiotherapy
10.1016/j.ijrobp.2004.11.009 · doi-reference
The current status of image-guided external beam radiotherapy for prostate cancer
10.1097/mou.0b013e32833817aa · doi-reference
A comprehensive assessment by tumor site of patient setup using daily MVCT imaging from more than 3,800 helical tomotherapy treatments
10.1016/j.ijrobp.2008.11.054 · doi-reference
Image-guided helical tomotherapy for localized prostate cancer: Technique and initial clinical observations
10.1120/jacmp.v8i3.2320 · doi-reference
Reduction of dose delivered to organs at risk in prostate cancer patients via image-guided radiation therapy
10.1016/j.ijrobp.2009.06.068 · doi-reference
The management of imaging dose during image-guided radiotherapy: Report of the AAPM Task Group 75
10.1118/1.2775667 · doi-reference
Examining margin reduction and its impact on dose distribution for prostate cancer patients undergoing daily cone-beam computed tomography
10.1016/j.ijrobp.2008.01.015 · doi-reference
Potentials of on-line repositioning based on implanted fiducial markers and electronic portal imaging in prostate cancer radiotherapy
10.1186/1748-717x-4-13 · doi-reference
On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma
10.1016/j.ijrobp.2004.03.038 · doi-reference
Low toxicity in inflammatory bowel disease patients treated with abdominal and pelvic radiation therapy
10.1097/coc.0000000000000010 · doi-reference
Evaluating toxicity from definitive radiation therapy for prostate cancer in men with inflammatory bowel disease: Patient selection and dosimetric parameters with modern treatment techniques
10.1016/j.prro.2014.09.004 · doi-reference
Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer
10.1016/j.ijrobp.2012.10.042 · doi-reference
Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience
10.1016/j.ijrobp.2007.01.067 · doi-reference
Radiation dose-volume effects and the penile bulb
10.1016/j.ijrobp.2009.04.094 · doi-reference
Radiation dose-volume effects of the urinary bladder
10.1016/j.ijrobp.2009.02.090 · doi-reference
Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial
10.1016/j.ijrobp.2013.07.041 · doi-reference
Late toxicity and quality of life after definitive treatment of prostate cancer: Redefining optimal rectal sparing constraints for intensity-modulated radiation therapy
10.1002/cam4.261 · doi-reference
Radiation dose-volume effects in radiation-induced rectal injury
10.1016/j.ijrobp.2009.03.078 · doi-reference
Guest editor's introduction to QUANTEC: A users guide
10.1016/j.ijrobp.2009.08.075 · doi-reference
Tolerance of normal tissue to therapeutic irradiation
10.1016/0360-3016(91)90171-y · doi-reference
Boosting imaging defined dominant prostatic tumors: A systematic review
10.1016/j.radonc.2013.04.027 · doi-reference
Clinician's guide to prostate IMRT plan assessment and optimisation
10.1111/j.1754-9485.2010.02217.x · doi-reference
Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate
10.1016/j.ijrobp.2006.10.039 · doi-reference
Impact of obesity on outcomes after definitive dose-escalated intensity-modulated radiotherapy for localized prostate cancer
10.1002/cncr.29472 · doi-reference
Implanted dosimeters identify radiation overdoses during IMRT for prostate cancer
10.1016/j.ijrobp.2011.12.094 · doi-reference
Interfractional prostate shifts: Review of 1870 computed tomography (CT) scans obtained during image-guided radiotherapy using CT-on-rails for the treatment of prostate cancer
10.1016/j.ijrobp.2008.03.045 · doi-reference
Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer
10.1016/j.ijrobp.2003.12.027 · doi-reference
Can megavoltage computed tomography reduce proton range uncertainties in treatment plans for patients with large metal implants?
10.1088/0031-9155/53/9/009 · doi-reference
Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy
10.1120/jacmp.v15i3.4611 · doi-reference
Anterior-oriented proton beams for prostate cancer: A multi-institutional experience
10.3109/0284186x.2014.986288 · doi-reference
Megavoltage CT in helical tomotherapy - clinical advantages and limitations of special physical characteristics
10.1177/153303460900800504 · doi-reference
A dosimetric study of volumetric modulated arc therapy planning techniques for treatment of low-risk prostate cancer in patients with bilateral hip prostheses
10.4103/2278-330x.126506 · doi-reference
Dosimetric considerations for patients with HIP prostheses undergoing pelvic irradiation. Report of the AAPM Radiation Therapy Committee Task Group 63
10.1118/1.1565113 · doi-reference
Effect of metal hip prosthesis on the accuracy of electromagnetic localization tracking
10.1016/j.prro.2014.03.010 · doi-reference
Stereotactic ultrasound for target volume definition in a patient with prostate cancer and bilateral total hip replacement
10.1016/j.prro.2014.08.008 · doi-reference